Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy

Christoffer Tobias Witt, Mads Brix Kronborg, Ellen Aagaard Nohr, Peter Thomas Mortensen, Christian Gerdes, Henrik Kjærulf Jensen, Jens Cosedis Nielsen

Research output: Contribution to journalJournal articleResearchpeer-review

Fingerprint Dive into the research topics of 'Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy'. Together they form a unique fingerprint.

Medicine & Life Sciences